| Year |
Citation |
Score |
| 2024 |
Han X, Zhang A, Wang P, Bi H, Ren K, Li E, Yang X, Aydemir I, Tao K, Lin J, Abdulkadir SA, Yang J, Ji P. Pleckstrin-2 Mediates the Activation of AKT in Prostate Cancer and Is Repressed by Androgen Receptor. The American Journal of Pathology. PMID 39069167 DOI: 10.1016/j.ajpath.2024.07.004 |
0.528 |
|
| 2024 |
Yoo YA, Quan S, Yang W, Guo Q, Rodríguez Y, Chalmers ZR, Dufficy MF, Lackie B, Sagar V, Unno K, Truica MI, Chandel NS, Abdulkadir SA. Asparagine Dependency is a Targetable Metabolic Vulnerability in TP53-Altered Castration-Resistant Prostate Cancer. Cancer Research. PMID 38959335 DOI: 10.1158/0008-5472.CAN-23-2910 |
0.498 |
|
| 2022 |
VanderWeele DJ, Kocherginsky M, Munir S, Martone B, Sagar V, Morgans A, Stadler WM, Abdulkadir S, Hussain M. A Phase II Study of sEphB4-HSA in Metastatic Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer. PMID 36210299 DOI: 10.1016/j.clgc.2022.08.012 |
0.491 |
|
| 2022 |
Holmes AG, Parker JB, Sagar V, Truica MI, Soni PN, Han H, Schiltz GE, Abdulkadir SA, Chakravarti D. A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expression. Science Advances. 8: eabh3635. PMID 35476451 DOI: 10.1126/sciadv.abh3635 |
0.523 |
|
| 2022 |
Rodríguez Y, Unno K, Truica MI, Chalmers ZR, Yoo YA, Vatapalli R, Sagar V, Yu J, Lysy B, Hussain M, Han H, Abdulkadir SA. A genome-wide CRISPR activation screen identifies PRRX2 as a regulator of enzalutamide resistance in prostate cancer. Cancer Research. PMID 35405009 DOI: 10.1158/0008-5472.CAN-21-3565 |
0.521 |
|
| 2022 |
Zenner ML, Helou YB, Deaton RJ, Sverdlov M, Wang H, Kajdacsy-Balla A, Macias V, Voisine C, Murray M, Abdulkadir SA, Murphy AB, Nonn L. Advanced glycation end-products (AGEs) are lower in prostate tumor tissue and inversely related to proportion of West African ancestry. The Prostate. 82: 306-313. PMID 34855273 DOI: 10.1002/pros.24273 |
0.409 |
|
| 2021 |
Desai AS, Sagar V, Lysy B, Weiner AB, Ko OS, Driscoll C, Rodriguez Y, Vatapalli R, Unno K, Han H, Cohen JE, Vo AX, Pham M, Shin M, Jain-Poster K, ... ... Abdulkadir SA, et al. Inflammatory bowel disease induces inflammatory and pre-neoplastic changes in the prostate. Prostate Cancer and Prostatic Diseases. PMID 34035460 DOI: 10.1038/s41391-021-00392-7 |
0.362 |
|
| 2021 |
Park SH, Fong KW, Kim J, Wang F, Lu X, Lee Y, Brea LT, Wadosky K, Guo C, Abdulkadir SA, Crispino JD, Fang D, Ntziachristos P, Liu X, Li X, et al. Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer. Science Advances. 7. PMID 33827814 DOI: 10.1126/sciadv.abe2261 |
0.503 |
|
| 2021 |
Unno K, Chalmers ZR, Pamarthy S, Vatapalli R, Rodriguez Y, Lysy B, Mok H, Sagar V, Han H, Yoo YA, Ku SY, Beltran H, Zhao Y, Abdulkadir SA. Activated ALK Cooperates with N-Myc via Wnt/β-catenin Signaling to Induce Neuroendocrine Prostate Cancer. Cancer Research. PMID 33637566 DOI: 10.1158/0008-5472.CAN-20-3351 |
0.442 |
|
| 2021 |
Chalmers ZR, Burns MC, Ebot EM, Frampton GM, Ross JS, Hussain MHA, Abdulkadir SA. Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2-ERG fusions. Prostate Cancer and Prostatic Diseases. PMID 33420417 DOI: 10.1038/s41391-020-00314-z |
0.416 |
|
| 2020 |
Thomas MU, Messex JK, Dang T, Abdulkadir SA, Jorcyk CL, Liou GY. Macrophages Expedite Cell Proliferation of Prostate Intraepithelial Neoplasia through Their Downstream Target ERK. The Febs Journal. PMID 32865335 DOI: 10.1111/febs.15541 |
0.473 |
|
| 2020 |
Koga Y, Song H, Chalmers ZR, Newberg J, Kim E, Carrot-Zhang J, Piou D, Polak P, Abdulkadir SA, Ziv E, Meyerson M, Frampton GM, Campbell JD, Huang FW. Genomic Profiling of Prostate Cancers from Men with African and European Ancestry. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32651179 DOI: 10.1158/1078-0432.Ccr-19-4112 |
0.352 |
|
| 2020 |
Meyers TJ, Weiner AB, Graff RE, Desai AS, Cooley LF, Catalona WJ, Hanauer SB, Wu JD, Schaeffer EM, Abdulkadir SA, Kundu SD, Witte JS. Association between inflammatory bowel disease and prostate cancer: A large-scale, prospective, population-based study. International Journal of Cancer. PMID 32399975 DOI: 10.1002/ijc.33048 |
0.338 |
|
| 2020 |
Burns MC, Sagar V, Jovanovic B, Morgans AK, VanderWeele DJ, Quinn DI, Stadler WM, Abdulkadir S, Hussain MHA. A phase II study of sEphB4-HSA in metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 38: TPS274-TPS274. DOI: 10.1200/Jco.2020.38.6_Suppl.Tps274 |
0.459 |
|
| 2020 |
Rajkumar-Calkins A, Sagar V, Wang J, Bailey S, Anderson P, Abdulkadir S, Kirschner AN. Inhibition of PIM kinase with fractionated radiation and docetaxel in preclinical prostate cancer models. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E17534 |
0.55 |
|
| 2019 |
Sagar V, Vatapalli R, Lysy B, Pamarthy S, Anker JF, Rodriguez Y, Han H, Unno K, Stadler WM, Catalona WJ, Hussain M, Gill PS, Abdulkadir SA. EPHB4 inhibition activates ER stress to promote immunogenic cell death of prostate cancer cells. Cell Death & Disease. 10: 801. PMID 31641103 DOI: 10.1038/S41419-019-2042-Y |
0.495 |
|
| 2019 |
Njoroge RN, Vatapalli RJ, Abdulkadir SA. Organoids Increase the Predictive Value of Cancer Chemoprevention Studies for Outcome. Frontiers in Oncology. 9: 77. PMID 30842936 DOI: 10.3389/fonc.2019.00077 |
0.359 |
|
| 2019 |
Richards Z, McCray T, Marsili J, Zenner ML, Manlucu JT, Garcia J, Kajdacsy-Balla A, Murray M, Voisine C, Murphy AB, Abdulkadir SA, Prins GS, Nonn L. Prostate Stroma Increases the Viability and Maintains the Branching Phenotype of Human Prostate Organoids. Iscience. 12: 304-317. PMID 30735898 DOI: 10.1016/J.Isci.2019.01.028 |
0.471 |
|
| 2019 |
Zarzour A, Morgans AK, Palmbos PL, Jovanovic B, Tomlins SA, VanderWeele DJ, Yang XJ, Schaeffer EM, Sharifi R, Meeks JJ, Abdulkadir S, Hussain MHA. Evaluating the clinical, environmental, genetic, and genomic profile of men with early-onset aggressive prostate cancer (PCa). Journal of Clinical Oncology. 37: TPS333-TPS333. DOI: 10.1200/Jco.2019.37.7_Suppl.Tps333 |
0.406 |
|
| 2019 |
Chalmers ZR, Frampton GM, Ross JS, Hussain MHA, Abdulkadir S. Age-related variation in gene alteration frequency in metastatic prostate cancer. Journal of Clinical Oncology. 37: 178-178. DOI: 10.1200/Jco.2019.37.7_Suppl.178 |
0.535 |
|
| 2018 |
Song B, Park SH, Zhao JC, Fong KW, Li S, Lee Y, Yang YA, Sridhar S, Lu X, Abdulkadir SA, Vessella RL, Morrissey C, Kuzel TM, Catalona WJ, Yang XJ, et al. Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression. The Journal of Clinical Investigation. PMID 30511964 DOI: 10.1172/Jci122367 |
0.36 |
|
| 2018 |
Yoo YA, Vatapalli R, Lysy B, Mok H, Desouki MM, Abdulkadir SA. The Role of Castration-Resistant Bmi1+Sox2+ Cells in Driving Recurrence in Prostate Cancer. Journal of the National Cancer Institute. PMID 30312426 DOI: 10.1093/jnci/djy142 |
0.492 |
|
| 2018 |
Anker JF, Naseem AF, Mok H, Schaeffer AJ, Abdulkadir SA, Thumbikat P. Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy. Nature Communications. 9: 1591. PMID 29686284 DOI: 10.1038/S41467-018-03900-X |
0.46 |
|
| 2018 |
Anker JF, Mok H, Naseem AF, Thumbikat P, Abdulkadir SA. A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer. Journal of Visualized Experiments : Jove. PMID 29578515 DOI: 10.3791/57301 |
0.458 |
|
| 2018 |
Carneiro BA, Pamarthy S, Shah AN, Sagar V, Unno K, Han H, Yang XJ, Costa RB, Nagy RJ, Lanman RB, Kuzel TM, Ross JS, Gay L, Elvin JA, Ali SM, ... ... Abdulkadir SA, et al. Anaplastic lymphoma kinase mutation (F1174C) in small cell carcinoma of the prostate and molecular response to alectinib. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29559559 DOI: 10.1158/1078-0432.CCR-18-0332 |
0.425 |
|
| 2017 |
Njoroge RN, Unno K, Zhao JC, Naseem AF, Anker JF, McGee WA, Nonn L, Abdulkadir SA. Organoids model distinct Vitamin E effects at different stages of prostate cancer evolution. Scientific Reports. 7: 16285. PMID 29176677 DOI: 10.1038/S41598-017-16459-2 |
0.346 |
|
| 2017 |
Unno K, Roh M, Yoo YA, Al-Shraideh Y, Wang L, Nonn L, Abdulkadir SA. Modeling African American prostate adenocarcinoma by inducing defined genetic alterations in organoids. Oncotarget. 8: 51264-51276. PMID 28881646 DOI: 10.18632/Oncotarget.17230 |
0.513 |
|
| 2017 |
Unno K, Roh M, Yoo YA, Al-Shraideh Y, Wang L, Nonn L, Abdulkadir SA. Modeling African American prostate adenocarcinoma by inducing defined genetic alterations in organoids. Oncotarget. PMID 28472770 DOI: 10.18632/oncotarget.17230 |
0.513 |
|
| 2017 |
Reinstein ZZ, Vatapalli R, Anker J, Pamarthy S, Carneiro B, Abdulkadir S. Abstract 1230: Talazoparib, a second generation PARP inhibitor, is a novel therapy for PTEN mutants in prostate cancer Cancer Research. 77: 1230-1230. DOI: 10.1158/1538-7445.Am2017-1230 |
0.61 |
|
| 2016 |
Yoo YA, Roh M, Naseem AF, Lysy B, Desouki MM, Unno K, Abdulkadir SA. Bmi1 marks distinct castration-resistant luminal progenitor cells competent for prostate regeneration and tumour initiation. Nature Communications. 7: 12943. PMID 27703144 DOI: 10.1038/Ncomms12943 |
0.448 |
|
| 2016 |
Kim JY, Yu J, Abdulkadir SA, Chakravarti D. KAT8 regulates androgen signaling in prostate cancer cells. Molecular Endocrinology (Baltimore, Md.). me20161024. PMID 27268279 DOI: 10.1210/Me.2016-1024 |
0.641 |
|
| 2015 |
Kirschner AN, Wang J, van der Meer R, Anderson PD, Franco-Coronel OE, Kushner MH, Everett JH, Hameed O, Keeton EK, Ahdesmaki M, Grosskurth SE, Huszar D, Abdulkadir SA. PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer. Journal of the National Cancer Institute. 107. PMID 25505253 DOI: 10.1093/Jnci/Dju407 |
0.521 |
|
| 2015 |
Carneiro BA, Meeks JJ, Kuzel TM, Scaranti M, Abdulkadir SA, Giles FJ. Emerging therapeutic targets in bladder cancer. Cancer Treatment Reviews. 41: 170-8. PMID 25498841 DOI: 10.1016/j.ctrv.2014.11.003 |
0.302 |
|
| 2014 |
Martinez EE, Darke AK, Tangen CM, Goodman PJ, Fowke JH, Klein EA, Abdulkadir SA. A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Prevention Research (Philadelphia, Pa.). 7: 950-7. PMID 24894197 DOI: 10.1158/1940-6207.CAPR-14-0075 |
0.439 |
|
| 2014 |
van der Meer R, Song HY, Park SH, Abdulkadir SA, Roh M. RNAi screen identifies a synthetic lethal interaction between PIM1 overexpression and PLK1 inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3211-21. PMID 24771642 DOI: 10.1158/1078-0432.Ccr-13-3116 |
0.467 |
|
| 2014 |
Holder SL, Abdulkadir SA. PIM1 kinase as a target in prostate cancer: roles in tumorigenesis, castration resistance, and docetaxel resistance. Current Cancer Drug Targets. 14: 105-14. PMID 24274399 DOI: 10.2174/1568009613666131126113854 |
0.481 |
|
| 2013 |
Logan M, Anderson PD, Saab ST, Hameed O, Abdulkadir SA. RAMP1 is a direct NKX3.1 target gene up-regulated in prostate cancer that promotes tumorigenesis. The American Journal of Pathology. 183: 951-63. PMID 23867798 DOI: 10.1016/j.ajpath.2013.05.021 |
0.602 |
|
| 2013 |
Katkoori VR, Manne K, Vital-Reyes VS, Rodríguez-Burford C, Shanmugam C, Sthanam M, Manne U, Chatla C, Abdulkadir SA, Grizzle WE. Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53 Biotechnic and Histochemistry. 88: 38-46. PMID 23167625 DOI: 10.3109/10520295.2012.724713 |
0.43 |
|
| 2013 |
Abdulkadir S, Meer RV, Roh M. Abstract 5185: RNAi screen identifies a synthetic lethal interaction between Pim1 overexpression and Plk1 inhibition. Cancer Research. 73: 5185-5185. DOI: 10.1158/1538-7445.Am2013-5185 |
0.589 |
|
| 2012 |
Martinez EE, Anderson PD, Logan M, Abdulkadir SA. Antioxidant treatment promotes prostate epithelial proliferation in Nkx3.1 mutant mice. Plos One. 7: e46792. PMID 23077524 DOI: 10.1371/journal.pone.0046792 |
0.521 |
|
| 2012 |
Anderson PD, McKissic SA, Logan M, Roh M, Franco OE, Wang J, Doubinskaia I, van der Meer R, Hayward SW, Eischen CM, Eltoum IE, Abdulkadir SA. Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis. The Journal of Clinical Investigation. 122: 1907-19. PMID 22484818 DOI: 10.1172/Jci58540 |
0.574 |
|
| 2011 |
Roh M, Meer RVd, Abdulkadir S. Abstract 4206: Tumorigenic polyploid cells contain elevated levels of reactive oxygen species and are selectively targeted by antioxidant treatment Cancer Research. 71: 4206-4206. DOI: 10.1158/1538-7445.Am2011-4206 |
0.387 |
|
| 2011 |
Logan M, Anderson P, Abdulkadir S. Abstract 2734: Genome-wide analysis of direct Nkx3.1 target genes Cancer Research. 71: 2734-2734. DOI: 10.1158/1538-7445.Am2011-2734 |
0.626 |
|
| 2011 |
McKissic S, Roh M, Abdulkadir S. Abstract 2401: Loss of Nkx3.1 cooperates with Myc overexpression to promote prostate tumorigenesis Cancer Research. 71: 2401-2401. DOI: 10.1158/1538-7445.Am2011-2401 |
0.56 |
|
| 2010 |
Kim J, Roh M, Abdulkadir SA. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity. Bmc Cancer. 10: 248. PMID 20515470 DOI: 10.1186/1471-2407-10-248 |
0.505 |
|
| 2010 |
Roh M, Abdulkadir SA. Targeting the endothelin receptor in prostate cancer bone metastasis: Back to the mouse? Cancer Biology & Therapy. 9: 615-7. PMID 20150768 DOI: 10.4161/Cbt.9.8.11309 |
0.393 |
|
| 2009 |
Kim J, Eltoum IE, Roh M, Wang J, Abdulkadir SA. Interactions between cells with distinct mutations in c-MYC and Pten in prostate cancer. Plos Genetics. 5: e1000542. PMID 19578399 DOI: 10.1371/Journal.Pgen.1000542 |
0.443 |
|
| 2008 |
Roh M, Franco OE, Hayward SW, van der Meer R, Abdulkadir SA. A role for polyploidy in the tumorigenicity of Pim-1-expressing human prostate and mammary epithelial cells. Plos One. 3: e2572. PMID 18596907 DOI: 10.1371/Journal.Pone.0002572 |
0.381 |
|
| 2007 |
Mogal AP, van der Meer R, Crooke PS, Abdulkadir SA. Haploinsufficient prostate tumor suppression by Nkx3.1: a role for chromatin accessibility in dosage-sensitive gene regulation. The Journal of Biological Chemistry. 282: 25790-800. PMID 17602165 DOI: 10.1074/Jbc.M702438200 |
0.545 |
|
| 2006 |
Roh M, Kim J, Song C, Wills M, Abdulkadir SA. Transgenic mice for Cre-inducible overexpression of the oncogenes c-MYC and Pim-1 in multiple tissues. Genesis (New York, N.Y. : 2000). 44: 447-53. PMID 17013838 DOI: 10.1002/Dvg.20235 |
0.336 |
|
| 2006 |
Yang SZ, Eltoum IA, Abdulkadir SA. Enhanced EGR1 activity promotes the growth of prostate cancer cells in an androgen-depleted environment. Journal of Cellular Biochemistry. 97: 1292-9. PMID 16552752 DOI: 10.1002/jcb.20736 |
0.531 |
|
| 2006 |
Mogal A, Abdulkadir SA. Effects of Histone Deacetylase Inhibitor (HDACi); Trichostatin-A (TSA) on the expression of housekeeping genes. Molecular and Cellular Probes. 20: 81-6. PMID 16326072 DOI: 10.1016/J.Mcp.2005.09.008 |
0.547 |
|
| 2005 |
Abdulkadir SA, Kim J. Genetically engineered murine models of prostate cancer: insights into mechanisms of tumorigenesis and potential utility. Future Oncology (London, England). 1: 351-60. PMID 16556009 DOI: 10.1517/14796694.1.3.351 |
0.363 |
|
| 2005 |
Abdulkadir SA. Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1. Annals of the New York Academy of Sciences. 1059: 33-40. PMID 16382041 DOI: 10.1196/annals.1339.018 |
0.446 |
|
| 2004 |
Gary B, Azuero R, Mohanty GS, Bell WC, Eltoum IE, Abdulkadir SA. Interaction of Nkx3.1 and p27kip1 in prostate tumor initiation. The American Journal of Pathology. 164: 1607-14. PMID 15111307 DOI: 10.1016/S0002-9440(10)63719-4 |
0.39 |
|
| 2004 |
Whiteside MA, Chen DT, Desmond RA, Abdulkadir SA, Johanning GL. A novel time-course cDNA microarray analysis method identifies genes associated with the development of cisplatin resistance. Oncogene. 23: 744-52. PMID 14737109 DOI: 10.1038/Sj.Onc.1207164 |
0.333 |
|
| 2004 |
Zayzafoon M, Abdulkadir SA, McDonald JM. Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines. The Journal of Biological Chemistry. 279: 3662-70. PMID 14602722 DOI: 10.1074/Jbc.M308158200 |
0.412 |
|
| 2004 |
Said-Al-Naief N, Roh M, Song C, Eltoum I, Gary B, Azuero R, Abdulkadir S. The expression of Pim-1 and Endothelin-1 in osteolytic and osteoblastic metastatic carcinoma to bone Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 98: 201-202. DOI: 10.1016/J.Tripleo.2004.06.032 |
0.377 |
|
| 2003 |
Yang SZ, Abdulkadir SA. Early growth response gene 1 modulates androgen receptor signaling in prostate carcinoma cells. The Journal of Biological Chemistry. 278: 39906-11. PMID 12890669 DOI: 10.1074/jbc.M307250200 |
0.545 |
|
| 2003 |
Magee JA, Abdulkadir SA, Milbrandt J. Haploinsufficiency at the Nkx3.1 locus. A paradigm for stochastic, dosage-sensitive gene regulation during tumor initiation. Cancer Cell. 3: 273-83. PMID 12676585 DOI: 10.1016/S1535-6108(03)00047-3 |
0.498 |
|
| 2002 |
Abdulkadir SA, Magee JA, Peters TJ, Kaleem Z, Naughton CK, Humphrey PA, Milbrandt J. Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia. Molecular and Cellular Biology. 22: 1495-503. PMID 11839815 DOI: 10.1128/Mcb.22.5.1495-1503.2002 |
0.506 |
|
| Show low-probability matches. |